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Abstract
Background: The effects of iron interventions and host iron status on infection risk have been a recurrent clinical
concern, although there has been little research on this interaction in pregnant women.
Methods: Cross-sectional and longitudinal analyses were undertaken to determine the association of whole blood
zinc erythrocyte protoporphyrin (ZPP) with malaria parasitaemia in pregnant women attending antenatal and
delivery care at Montfort and Chikwawa Hospitals, Shire Valley, Malawi. Prevalence of antenatal, delivery and
placental malaria was assessed in relation to maternal ZPP levels. The main outcome measures were prevalence of
peripheral and placental Plasmodium falciparum parasitaemia and odds ratios of malaria risk.
Results: A total of 4,103 women were evaluated at first antenatal visit, of whom at delivery 1327 were screened for
peripheral and 1285 for placental parasitaemia. Risk of malaria at delivery (peripheral or placental) was higher in
primigravidae (p< 0.001), and lower (peripheral) with use of intermittent preventive anti-malarials during pregnancy
(p< 0.001). HIV infection was associated with increased malaria parasitaemia (p< 0.02, peripheral or placental).
Parasitaemia prevalence was lower in women with normal ZPP levels compared to those with raised concentrations
at both first antenatal visit (all gravidae, p = 0.048, and at delivery (all gravidae, p< 0.001; primigravidae, p = 0.056).
Between first antenatal visit and delivery women who transitioned from raised (at first antenatal visit) to normal ZPP
values (at delivery) had lower peripheral parasitaemia prevalence at delivery compared to those who maintained
normal ZPP values at both these visits (all gravidae: 0.70, 95%CI 0.4-1.1; primigravidae: 0.3, 0.1-0.8). In regression
analysis this difference was lost with inclusion of HIV infection in the model.
Conclusions: Raised ZPP concentrations in pregnancy were positively associated with P. falciparum parasitaemia
and were probably secondary to malaria inflammation, rather than indicating an increased malaria risk with iron
deficiency. It was not possible from ZPP measurements alone to determine whether iron deficiency or repletion
alters malaria susceptibility in pregnancy.
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Background
The effects of iron interventions and host iron status on
infection risk have been a recurrent clinical concern [1]
and this interaction has been examined in several meta-
analyses [2-4] and a Cochrane Review [5]. Concerns
have focused mainly on possible harmful effects of
treating iron deficiency [5], rather than on the effects
of iron status itself on infection risk. There has been
little research on this interaction in pregnant women,
in whom iron supplementation studies have focused
on anaemia and birth-weight outcomes rather than
infection [6].
Two previous cross-sectional studies in Malawi [7]
and Tanzania [8] reported that maternal iron deficiency
was associated with reduced risk of placental malaria.
Iron status was assessed using either the serum transfer-
rin receptor: log ferritin ratio [7], or serum ferritin
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corrected for elevated C - reactive protein [8]. These
studies suggested that iron biomarkers may be useful
predictors of malaria risk in pregnancy. An alternative
iron biomarker, red cell zinc protoporhyrin/haem (ZPP),
has the relative advantage of low cost and simplicity. Al-
though in children with infection, inflammation, or high
malaria parasite densities, ZPP specificity may be
reduced [9-11]. In a cohort study in young children,
baseline ZPP levels alone were used as an iron bio-
marker for defining iron deficiency and for assessing
malaria incidence over 600 days [12]. This study showed
that anaemic children with iron deficiency who received
iron and folic acid supplementation had lower malaria-
related adverse events than children receiving placebo,
although the analysis did not control for malaria treat-
ments given. No studies were identified which examined
host iron status based on ZPP as a predictor of malaria
risk in pregnant women. The rationale for the present
study was to determine the association of ZPP with
malaria risk in pregnancy. Cross-sectional malaria
prevalence was assessed at first antenatal visit, and also
in longitudinal ZPP categories for women seen at both
first antenatal visit and at delivery, allowing a possible
directional influence of gestational iron status to be
assessed.
The data for the analysis was collected between
1992–1995 in a large study, which described the pattern
of malaria and anaemia during pregnancy and associa-
tions with pregnancy outcomes [13-15]. The analysis of
this large data set allowed the utility of ZPP to be
assessed as a potential biomarker of malaria risk both
at first antenatal visit, prior to commencement of rou-
tine haematinic supplementation with iron and folic
acid, and at delivery following several weeks of haemati-
nic supplementation. This is the first analysis of malaria
risk in pregnancy using ZPP as a biomarker of host
iron status.
Methods
Study design
Cross-sectional and longitudinal analyses of whole blood
zinc erythrocyte protoporphyrin (ZPP) were conducted
in order to determine its association with malaria para-
sitaemia prevalence in pregnant women attending for
antenatal and delivery care.
Study location
Study enrolment was between March 1993 and July
1994 in Chikwawa District, Southern Malawi, a rural
area with holo-endemic malaria transmission at the time
of the study, and was located in two hospitals: Chikwawa
District Hospital (CDH), a government hospital with free
services, and Montfort Hospital (MH) 30 km away,
which is a fee-paying mission hospital.
Study sample
All women attending the antenatal facilities of CDH or
MH were screened at their first antenatal visit. Verbal
informed consent was obtained. Women were encour-
aged to deliver in the hospital facilities and those who
attended for delivery were screened a second time. Most
women received two intermittent treatment doses of
sulphadoxine-pyrimethamine (sulphadoxine 1,500 mg;
pyrimethamine 75 mg) (IPTp-SP), one at the time of
their first antenatal visit (if after the first trimester), and
a second dose at between 28–34 weeks gestation [13].
Enrolment and delivery procedures
At enrolment a questionnaire was completed on obstet-
ric history. Mid upper-arm circumference (MUAC) was
measured in women at the mid-point of the left arm
(mm) and height (cms) using a height board. Each sub-
ject was given a month’s supply of haematinics (ie, 30
tablets containing 200 mg ferrous sulphate and 250 μg
folic acid) at every antenatal visit and asked to visit
monthly. At-delivery frequency of use of sulphadoxine-
pyrimethamine was available from the antenatal card.
A venipuncture blood sample was collected in an EDTA
tube at first antenatal visit and also immediately prior to
delivery. Within six hours of collection, haemoglobin
(Hb) concentration was measured photometrically by
conversion to cyanomethemoglobin (Biotron hemoglo-
binometer) using a standard control. Within 24 hours
packed cell volume (PCV) was measured by micro-
haematocrit), and ZPP in μg ZP/gHb (AVIV hematofluo-
rometer). ZPP measurements were standardised against
manufacturer control samples. Mean corpuscular
haemoglobin concentration (MCHC) was calculated
from Hb and PCV. Sera of mothers, whose babies were
included in a separate infant follow-up study, were HIV
tested after maternal informed consent and counselling.
Maternal HIV infection was defined by presence of HIV
antibodies determined by ICE* HIV-1.02 (Minex, Dart-
ford, UK) and confirmed by VIDAS HIV-2 test (Bio
Merieux, Lyon, France). At the time of the study, anti-
retroviral therapy was not available, nor Co-trimoxazole
prophylaxis, so women did not receive these drugs. Mal-
aria slides were prepared and stained with Giemsa and
read counting asexual Plasmodium falciparum parasites
against 200 white blood cells. A malaria smear was pre-
pared from blood obtained from 1 cm placental villous
incision.
Definitions
Anaemia was defined as Hb <11 g/dl, severe anaemia as
Hb <8 g/dl, and iron-deficient erythropoiesis as ZPP
concentration> 2.7 μg ZP/g Hb [14,16]. Low MCHC
was defined as <32 g/d [17]. Longitudinal iron transition
categories (iron deficient or replete) were defined, based
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on raised or normal ZPP categories, for women screened
at both first antenatal visit and at delivery. The four lon-
gitudinal transition categories refer to subjects with ZPP
and malaria data both at first antenatal visit and at deliv-
ery. These were: (1) iron replete at first antenatal visit
and at delivery; (2) iron deficient at first antenatal visit
and iron replete at delivery; (3) iron deficient at first
antenatal visit and at delivery; (4) iron replete at first
antenatal visit and iron deficient at delivery. Peripheral
parasitaemia refers to detection of P. falciparum para-
sites on a blood smear from a venipuncture sample col-
lected at first antenatal visit or delivery. Placental
parasitaemia was a positive P. falciparum blood smear
obtained from a sample collected following placental vil-
lous incision.
Analysis
Cross-sectional analyses measured malaria parasitaemia
prevalence and ZPP concentration at either first ante-
natal visit or at delivery. Malaria prevalence was esti-
mated for women with normal or raised ZPP levels.
Longitudinal analyses classified ZPP transition categories
(raised or normal values), which occurred between the
first antenatal visit and delivery, and related these to ei-
ther placental or peripheral parasitaemia prevalence at
delivery. Data were analysed using SPSS for Windows
version 18. Discrete variables were compared using chi-
square tests. For the longitudinal data set multivariate
logistic regression was used to calculate odds ratios for
factors associated with delivery malaria as the dependent
variable (peripheral or placental parasitaemia). Factors
included in the regression models were intermittent use
of sulphadoxine-pyrimethamine in pregnancy (IPTp),
gravidity, maternal HIV status, and longitudinal ZPP
transition category.
Ethical approval for the study was granted by the Ma-
lawi Health Science and Research Committee, and the
Liverpool School of Tropical Medicine.
Results
The sample sizes available for the analysis are shown in
Figure 1. At the first antenatal visit (n = 4,103) blood
clotting or haemolysis prevented determination of ZPP
for 133 women (3.2 %). Of women with a ZPP measure-
ment 3793 (95.5 %) had an available malaria smear. The
number of placental blood samples was lower than for
peripheral blood at delivery as a small number of placen-
tas were not available for sampling (placental retention,
unsuitable specimen or discarded before sampling). HIV
status was available for 630 women.
Prevalence of demographic and nutritional characteris-
tics at first antenatal visit is shown in Table 1. Mean
Figure 1 Cross-sectional and longitudinal sample sizes. Cross-sectional refers to samples available at either first antenatal visit or at delivery.
Longitudinal categories refers to the four longitudinal transition categories of subjects with ZPP and malaria data both at first antenatal visit and
at delivery. These were: (1) iron replete at first antenatal visit and at delivery; (2) iron deficient at first antenatal visit and iron replete at delivery; (3)
iron deficient at first antenatal visit and at delivery; (4) iron replete at first antenatal visit and iron deficient at delivery.
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gestational age at first attendance for primigravidae was
20.5 weeks (SD± 2.8), and multigravidae 21.9 weeks (±
6.2). One fifth of subjects were adolescent (21.7 %), or
primigravidae (19.9 %). Most women were anaemic and
those with parasitaemia were mainly asymptomatic. Ap-
proximately a quarter of primigravidae and two thirds of
multigravidae were iron deficient based on the ZPP
measurement alone. Malaria prevalence was significantly
higher in primigravidae than multigravidae (P< 0.001).
HIV infection prevalence was 25.4 %.
Cross-sectional analysis
Table 2 summarizes malaria prevalence at first antenatal
visit and at delivery, stratified by raised and/or normal
ZPP values. At first antenatal visit, and for all gravidae
classes, malaria prevalence was higher in women with
raised ZPP values (ZPP >2.7 μgZP/gHb) (p = 0.048). At
delivery there was also a higher peripheral parasitaemia
prevalence with raised ZPP values for all gravidae
combined (p< 0.001). Placental malaria prevalence was
higher for all gravidae in women with raised ZPP values,
although this difference was not significant.
There were no differences in malaria prevalence at ei-
ther first antenatal visit or delivery (peripheral or placen-
tal) between women with normal or low MCHC values,
except for multigravidae at first antenatal visit with low
MCHC, who had lower malaria prevalence, compared to
those with normal MCHC (12.1 % versus 15.1 %, 0.80,
0.64-1.00, p = 0.048).
Longitudinal analysis
Prevalence estimates for peripheral or placental malaria
at delivery for the four iron transition categories based
on ZPP measurements are shown in Table 3. Delivery
malaria prevalence was lowest (peripheral or placental
blood) in women who were classified as iron deficient at
first antenatal visit and replete at delivery (category 2)
when compared with other ZPP transition categories.
This difference was significant for peripheral parasit-
aemia in primigravidae (relative risk 0.34, 95 % CI 0.14-
0.83). Women with raised ZPP values at first antenatal
visit and at delivery (possible chronic iron deficiency;
category 3) had higher malaria prevalence at delivery
than women with normal ZPP values at both the ante-
natal visit and at delivery (possible iron replete), (all
gravidae: 1.38, 1.01-1.87; multigravidae: 1.52, 1.01-2.27).
Table 1 Participant characteristics at first antenatal visit
Characteristic n %
Age ≤19 years* 2,839 21.7
Haemoglobinconcentration
atfirst antenatal visit (1st ANV)
Hb< 11 (g/dL)
4,071 88.9
Mid- upper arm
circumference ( <23 cm)
3,746 7.4
Primigravidae 4,103 19.9
Secundigravidae 4,103 17.3
Multigravidae 4,103 62.8
Body mass index
(BMI) (<18.5 kg/m2)
4,037 7.5
Nutrition status (BMI
< 18.5 and MUAC <23 cm)
4,002 2.6
ZPP >2.7 μg ZP/g Hb 1st ANV All gravidae 3,970 44.9
Primigravidae 788 23.1
Secundigravidae 690 17.8
Multigravidae 2,492 59.1
MCHC <32.0 g/dL 1st ANV All gravidae 3,729 45.6
Primigravidae 752 20.9
Secundigravidae 650 17.8
Multigravidae 2,327 61.4
Peripheral malaria at 1stANV Primigravidae 779 35.3
Secundigravidae 673 21.2
Multigravidae 2,462 13.2
HIV positive All gravidae 630 25.4
Primigravidae 158 19.6
Multigravidae 472 27.3
n: available sample.
*For participants who knew their age.
BMI: body mass index: weight, kg/ height, m2 ; ANV : antenatal visit.
Table 2 Malaria prevalence at first antenatal visit and
delivery by ZPP concentration
Gravida ZPP, μg ZP/g Hb RR (95 % CI) P value
>2.7 ≤2.7
First ANV % (n) % (n)
All Gravida 20.0 (2218) 17.5 (1575) 1.15 (1.00 – 1.31) 0.048
PG 36.3 (513) 32.6 (242) 1.11 (0.90 – 1.38) 0.33
SG 20.6 (393) 22.5 (262) 0.92 (0.68 – 1.23) 0.56
MG 13.5 (1311) 12.8 (1071) 1.06 (0.86 – 1.30) 0.61
Delivery
All Gravida 23.8 (960) 15.2 (407) 1.56 (1.21 – 2.02) <0.001
PG 38.7 (217) 26.8 (82) 1.44 (0.97 – 2.14) 0.056
SG 26.4 (163) 20.6 (63) 1.28 (0.74 – 2.21) 0.37
MG 17.4 (580) 10.3 (262) 1.69 (1.13 – 2.52) 0.008
Placenta
All Gravida 19.0 (935) 15.6 (390) 1.22 (0.93 – 1.59) 0.14
PG 34.6 (211) 31.3 (80) 1.11 (0.76 – 1.61) 0.59
SG 21.8 (156) 18.2 (55) 1.20 (0.64 – 2.26) 0.57
MG 12.5 (568) 10.2 (255) 1.23 (0.80 – 1.87) 0.34
Brackets: available sample.
ZPP: zinc erythrocyte protoporphyrin.
ANV: antenatal visit.
PG: primigravida; SG: secundigravida; MG: multigravida; RR: relative risk.
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Table 4 summarizes participant characteristics for
the four ZPP transition categories. IPTp uptake was
highest in women in category 2 (p< 0.05 for all category
comparisons). Other characteristics did not differ signifi-
cantly between categories, except for anaemia (Hb
<11 g/dl and <8 g/dl), which had lowest prevalence in
category 1 (iron replete at both visits) (p< 0.001).
For the longitudinal data set logistic regression ana-
lysis using two models was performed with malaria at
delivery as the dependent variable. Models were based
on the ZPP cut-off used to define iron deficiency. Fac-
tors included were gravidae, IPTp uptake ≥ one dose,
and ZPP transition categories 1–4. The second model
included HIV status as only a subsample of women
(16 %) had known HIV status. Risk of malaria at delivery
(peripheral or placental) was higher in primigravidae (p
< 0.001), and lower (peripheral) with IPTp use (p
< 0.001). HIV infection was associated with increased
malaria risk (p< 0.02, peripheral or placental). There
was lower risk of peripheral parasitaemia at delivery for
women who transitioned from raised ZPP at first ante-
natal visit to normal ZPP values at delivery (p = 0.048)
(ZPP category 2). This reduced risk remained in model
2, which included HIV status, but was no longer
significant.
Discussion
This is the first analysis of ZPP as a potential iron bio-
marker of malaria risk in pregnancy. Use of ZPP transi-
tion categories allowed malaria risk to be assessed
concurrently with longitudinal changes in this iron bio-
marker. Gestational iron status is influenced by antenatal
haematinic use, iron bioavailability [18] and enteric iron
losses. Under the high malaria exposure in which these
women were living, a higher malaria prevalence in
primigravidae than multigravidae would be expected
[19], and was observed across all ZPP transition categor-
ies, indicating the substantial influence of parity on
malaria susceptibility under these malaria-endemic con-
ditions. Almost two thirds of multigravidae and a quar-
ter of primigravidae would be classified as iron deficient,
Table 3 Plasmodium falciparum prevalence (%) and risk estimates at delivery in four ZPP transition categories by
gravida
Iron Transition Peripheral parasitaemia Placental parasitaemia
All Gravida PG MG All Gravida PG MG
RR(95%CI) RR(95%CI) RR(95%CI) RR(95%CI) RR(95%CI) RR(95%CI)
ZPP
Category 17.4 (242) 39.0 (41) 12.9 (201) 18.3 (230) 40.0 (40) 13.7 (190)
1 Refs Refs Refs Refs Refs Refs
Category 11.5 (148) 13.2 (38) 10.9 (110) 11.9 (143) 21.6 (37) 8.5 (106)
2 0.7 0.3 0.8 0.6 0.5 0.6
(0.4-1.1) (0.1-0.8) (0.4-1.6) (0.4-1.1) (0.3-1.1) (0.3-1.3)
Category 23.9 (628) 37.0 (154) 19.6 (474) 20.4 (612) 34.5 (148) 15.9 (464)
3 1.4 0.9 1.5 1.1 0.9 1.2
(1.0-1.9) (0.6-1.5) (1.0-2.3) (0.8-1.5) (0.6-1.3) (0.8-1.8)
Category 23.0 (309) 44.1 (59) 18.0 (250) 16.0 (300) 33.9 (59) 11.6 (241)
4 1.3 1.1 1.4 0.9 0.8 0.8
(0.9-1.9) (0.7-1.8) (0.9-2.2) (0.6-1.3) (0.5-1.4) (0.5-1.4)
Brackets: available sample, or 95 % confidence interval.
ZPP: zinc erythrocyte protoporphyrin;
Category 1: ZPP normal to ZPP normal.
Category 2: Raised ZPP to normal ZPP.
Category 3: Raised ZPP to raised ZPP.
Category 4: Normal ZPP to raised ZPP.
Table 4 Prevalence (%) of study characteristics in the four
longitudinal ZPP transition categories
Characteristic ZPP Category
1 2 3 4
Primigravidae 17.3 (249) 25.5 (157) 24.6 (642) 18.8 (320)
IPTp-SP ≥1dose 72.0 (246) 81.3 (150) 68.1 (627) 62.9 (310)
Hb< 11 g/dl 58.4 (243) 62.7 (150) 87.4 (628) 76.1 (305)
Hb< 8 g/dl 2.1 (243) 8.7 (150) 18.0 (628) 9.2 (305)
LBW< 2500 g 13.5 (245) 19.1 (152) 19.0 (633) 15.2 (309)
HIV positive 23.7 (97) 37.7 (61) 20.5 (268) 30.0 (130)
Brackets: available sample.
IPTp-SP: intermittent preventive treatment with sulfadoxine – pyrimethamine;
Hb:hemoglobin; LBW: low birth weight; ZPP: zinc erythrocyte protoporphyrin.
Category 1: ZPP normal to ZPP normal.
Category 2: Raised ZPP to normal ZPP.
Category 3: Raised ZPP to raised ZPP.
Category 4: Normal ZPP to raised ZPP.
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based on either the ZPP measurement alone, and
approximately 90 % were anaemic.
ZPP reflects bone marrow iron requirements [20], and
as ZPP and haemoglobin are diluted equally during
pregnancy due to plasma volume expansion, the use of a
ZPP/haemoglobin index avoids misinterpretation that
may result from plasma volume changes. In a non-
malarious area the diagnostic sensitivity and predictive
value of ZPP for evaluating iron depletion and risk of
anaemia in pregnancy compared favourably to those of
ferritin and transferrin saturation measurements.[21].
Expansion of plasma volume is greater than that of red
cell mass and leads to a decline in haemoglobin and
haematocrit [18], with little change in average red-cell
haemoglobin concentration, or MCHC [16]. MCHC is,
therefore, a useful indicator of iron deficiency although
by definition it can only diagnose iron deficiency at the
stage of anaemia. Based on a MCHC <32 g/dl, approxi-
mately one in five primigravidae and three in five multi-
gravidae would be classified as iron deficient. MCHC
may be a poor biomarker when calculated from micro-
haematocrit without frequent calibration.
In the cross-sectional analysis at first antenatal visit,
malaria prevalence was higher in women with raised
ZPP values for all gravidae classes except secundigravi-
dae. At delivery, malaria prevalence (peripheral or pla-
cental blood) was also higher in woman with raised ZPP
concentrations. This association in the cross-sectional
study of higher malaria prevalence in women with ele-
vated ZPP levels is the statistically most significant find-
ing as in the longitudinal sub-group analyses sample
sizes are much smaller. The association may result from
inflammation increasing ZPP concentration, rather than
indicating an association of increased malaria risk with
maternal iron deficiency. This is because, based on
MCHC, multigravidae at first antenatal visit who had
low MCHC values also had lower malaria prevalence
compared to those with normal MCHC, suggesting that
iron deficiency may reduce malaria risk. This suggests
ZPP is not a good biomarker for iron status in this
population. A limitation of ZPP as an indicator of preg-
nancy iron status relates to factors known to elevate its
concentration, including infection [22], impaired iron
utilization in chronic inflammation [23], chronic malarial
haemolysis sufficient to result in iron demand in excess
of the iron transport system’s ability to deliver iron to
the red cell, and drug intake, for example with cotrimox-
azole [20]. All of these factors are common in women
living under conditions of high malaria exposure and
some of these factors may explain the association in the
present study of raised ZPP values with increased mal-
aria prevalence. Raised bilirubin concentration, second-
ary to haemolysis could also interfere with
haematoflourometer readings when whole blood samples
were used [24,25], and use of washed red cells would
have been preferable. Very high levels of zinc protopor-
phyrin may be toxic to the malaria parasite [26], and in
very anaemic Tanzanian children reduced malaria risk
was reported with raised ZPP concentration [11].
In the present study gravidae who maintained normal
ZPP concentrations at first antenatal visit and at delivery
(i e, possibly iron replete throughout pregnancy), had
higher delivery malaria prevalence than those who tran-
sitioned from raised to normal ZPP values (i e, became
iron replete in late pregnancy). This might suggest that
continuous iron repletion during gestation was asso-
ciated with higher delivery malaria risk, and not late ges-
tational iron repletion. But women with continuous iron
repletion did not have higher delivery malaria prevalence
than women who transitioned to raised ZPP values at
delivery (i e, were iron deficient late in pregnancy, or
throughout pregnancy), suggesting that if ZPP is accur-
ately indicating maternal iron status then it is not dis-
criminating malaria risk, as both chronically iron-replete
and chronically iron-deficient women were at equivalent
risk of malaria at delivery. However, if malaria-related in-
flammation raises ZPP concentration, independent of
maternal iron status, then gestational transition to lower
ZPP values would be associated with a reduction in mal-
aria prevalence at delivery compared to women who
show no change in ZPP concentration, as shown in this
study.
In regression analysis, peripheral or placental malaria
was positively associated with primigravidae and HIV in-
fection, and lower malaria risk was associated with up-
take of one or more doses of IPTp-SP. These
associations would be expected and their magnitude
provides a useful gauge against which to assess malaria
risk estimates related to ZPP categories. Transition to
normal ZPP concentration was associated with reduced
risk for malaria parasitaemia in peripheral or placental
blood (Table 5). These findings are consistent with data
from the cross-sectional analysis at first antenatal visit
and delivery and suggest that malaria parasitaemia ele-
vates ZPP concentration. If antiretroviral therapy were
available, as was not the case at the time of this study,
then the host inflammatory response may be less
marked, and as a consequence ZPP as a biomarker of
iron status might have better validity.
A proportion of women in this population will have
raised ZPP concentrations solely related to maternal iron
deficiency and not related to inflammation. A limitation
of this analysis is that without additional sensitive serum
biomarkers of iron status it is not possible to discrimin-
ate this group from those with raised ZPP values due to
inflammation alone. For this reason it is not possible to
determine from ZPP measurements alone whether iron
deficiency or repletion alters malaria susceptibility in
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these pregnant women. The proportions of women with
raised ZPP values due to iron deficiency, or due to in-
flammation will also vary between gravidae as iron defi-
ciency is generally more frequent in multigravidae [27].
Conclusion
Analysis of ZPP as an iron biomarker from this large
pregnancy data set provides evidence that elevation of
ZPP concentration was associated with increased risk of
malaria infection, and that this association was second-
ary to inflammation rather than indicating increased
malaria risk with maternal iron deficiency. It was not
possible from ZPP measurements alone to determine
whether iron deficiency or repletion alters malaria sus-
ceptibility in pregnancy.
Abbreviation
ZPP: Zinc erythrocyte Protoporphyrin.
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